Ultragenyx Pharmaceutical Inc. (LON:0LIF)

Ultragenyx Pharmaceutical Revenue

In the year 2025, Ultragenyx Pharmaceutical had annual revenue of $673.00M USD with 20.13% growth. Ultragenyx Pharmaceutical had revenue of $207.00M in the quarter ending December 31, 2025, with 25.55% growth.

• Revenue: $673.00M
• Revenue Growth: +20.13%
• P/S Ratio: 3.59
• Revenue / Employee: $520.09K
• Employees: 1,294
• Market Cap: 1.69B GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	673.00M	112.77M	20.13%
Dec 31, 2024	560.23M	125.98M	29.01%
Dec 31, 2023	434.25M	70.92M	19.52%
Dec 31, 2022	363.33M	11.92M	3.39%
Dec 31, 2021	351.41M	80.38M	29.66%
Dec 31, 2020	271.03M	167.32M	161.32%
Dec 31, 2019	103.71M	52.22M	101.41%
Dec 31, 2018	51.50M	48.88M	1,871.48%
Dec 31, 2017	2.61M	2.48M	1,863.91%
Dec 31, 2016	133.00K	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	-	-	-
Dec 31, 2012	-	-	-
Dec 31, 2011	-	-	-